The issue: hydrOXYzine 50 mg/mL injection is not currently available to order and ETA for resupply is unknown at this time. Based on historical use, NH has approximately 2 to 3 weeks of stock in pharmacies and wardstock locations.
Newsroom
The issue: fluorescein ophthalmic products (1 mg strips and 2% drops, unit dose minims) remain only intermittently available. Supply of the fluorescein 2% minims is low at most NH sites; however, the fluorescein 1 mg strips are currently in good supply.
Join Dr. Andrew Deonarine, Dr. Dana Cole, and Bjorn Butow on June 15 (from 5-6 pm) on Zoom for a discussion about Northern Health’s SaferCare plan.
The Issue: The single source vendor of lidocaine 2% with EPINEPHrine 1:100,000 X 20 mL vials is on backorder. NH has approximately five to six weeks of supply on hand in pharmacies and in wardstock areas based on historical use.
Resolution: Methotrimeprazine 25 mg/mL injectable is now available in good supply and this drug shortage can be considered resolved.
Issue: Scopolamine 1.5 mg transdermal patch has been discontinued in Canada. NH has low supply on hand across all facilities. Scopolamine transdermal patch is indicated for prevention of motion sickness and is also used off-label for respiratory congestion in palliative care.
The Issue: The framycetin/gramicidin/dexamethasone (5 mg-0.05 mg-0.5 mg/mL) eye/ear drops (Sofracort®) are on backorder by the sole manufacturer, Sanofi. NH has approximately 8 weeks of supply on hand in pharmacies.